Comparison Overview
AbbVie | Neuroscience
AbbVie | Neuroscience
N/A
Last Update: 19/03/2026
Follow AbbVie’s Neuroscience page for news and updates about our commitment to help those living with and affected by the realities of neurological and psychiatric disorders such as Alzheimer’s disease, bipolar disorder and depression, major depressive disorder, migrain...
AbbVie
1 Waukegan Road, North Chicago, 60064, US
Last Update: 07/10/2026
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, ...
Compliance Ranges Comparison
AbbVie | Neuroscience
AbbVie
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for AbbVie | Neuroscience in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
AbbVie has 0.99% fewer incidents than the average of all companies with at least one recorded incident.
Incident History - AbbVie | Neuroscience (X = Date, Y = Severity)
AbbVie | Neuroscience cyber incidents detection timeline including parent company and subsidiaries.
Incident History - AbbVie (X = Date, Y = Severity)
AbbVie cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
AbbVie | Neuroscience
AbbVie
FAQ
Latest Global CVEs
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.
IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.
IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.
IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.